Eloxx Pharmaceuticals, Inc.
Recent Filings
All 1,000 filings →| Form | Description | Date |
|---|---|---|
| 10-K | 10-K | Mar 17, 2026 |
| NT 10-Q | NT 10-Q | Aug 14, 2025 |
| 8-K | FORM 8-K | Aug 12, 2025 |
| NT 10-Q | NT 10-Q | May 15, 2025 |
| NT 10-K | NT 10-K | Apr 1, 2025 |
| SEC STAFF ACTION | — | Feb 21, 2025 |
| 4 | OWNERSHIP DOCUMENT | Jan 28, 2025 |
| 4 | OWNERSHIP DOCUMENT | Jan 28, 2025 |
| 4 | OWNERSHIP DOCUMENT | Jan 28, 2025 |
| 4 | OWNERSHIP DOCUMENT | Jan 28, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Walts Alan Edmund | — | Award / Grant | 12,000 | 12,942 | Oct 16, 2024 |
| Androski Lindsay | — | Award / Grant | 12,000 | 12,000 | Oct 16, 2024 |
| Rubin Steven D | — | Award / Grant | 12,000 | 12,000 | Oct 16, 2024 |
| Aggarwal Sumit | PRESIDENT AND CEO | Award / Grant | 165,000 | 169,930 | Oct 16, 2024 |
| Geffken Daniel E. | INTERIM CFO | Purchase | 50,000 @ $0.72 | 50,000 | Nov 29, 2021 |
| PAREKH RAJESH B | — | Purchase | 2,381,890 @ $1.35 | 4,827,129 | May 13, 2021 |
| Pontifax Management 4 G.P. (2015) Ltd. | — | Purchase | 1,280,624 @ $1.35 | 1,791,470 | May 13, 2021 |
| Nussbaum Ran | — | Purchase | 1,280,624 @ $1.35 | 1,791,470 | May 13, 2021 |
| Kariv Tomer | — | Purchase | 592,592 @ $1.35 | 616,592 | May 13, 2021 |
| PAREKH RAJESH B | — | Award / Grant | 2,445,239 | 2,445,239 | Apr 1, 2021 |